1. Home
  2. IFRX vs WFCF Comparison

IFRX vs WFCF Comparison

Compare IFRX & WFCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFRX
  • WFCF
  • Stock Information
  • Founded
  • IFRX 2007
  • WFCF 1996
  • Country
  • IFRX Germany
  • WFCF United States
  • Employees
  • IFRX N/A
  • WFCF N/A
  • Industry
  • IFRX Biotechnology: Pharmaceutical Preparations
  • WFCF Computer Software: Prepackaged Software
  • Sector
  • IFRX Health Care
  • WFCF Technology
  • Exchange
  • IFRX Nasdaq
  • WFCF Nasdaq
  • Market Cap
  • IFRX 53.5M
  • WFCF 59.1M
  • IPO Year
  • IFRX 2017
  • WFCF 2011
  • Fundamental
  • Price
  • IFRX $1.43
  • WFCF $13.25
  • Analyst Decision
  • IFRX Strong Buy
  • WFCF
  • Analyst Count
  • IFRX 5
  • WFCF 0
  • Target Price
  • IFRX $7.40
  • WFCF N/A
  • AVG Volume (30 Days)
  • IFRX 492.5K
  • WFCF 4.3K
  • Earning Date
  • IFRX 11-07-2025
  • WFCF 11-11-2025
  • Dividend Yield
  • IFRX N/A
  • WFCF N/A
  • EPS Growth
  • IFRX N/A
  • WFCF N/A
  • EPS
  • IFRX N/A
  • WFCF 0.39
  • Revenue
  • IFRX $191,224.00
  • WFCF $25,604,000.00
  • Revenue This Year
  • IFRX N/A
  • WFCF N/A
  • Revenue Next Year
  • IFRX $1,216.24
  • WFCF N/A
  • P/E Ratio
  • IFRX N/A
  • WFCF $33.80
  • Revenue Growth
  • IFRX 54.36
  • WFCF N/A
  • 52 Week Low
  • IFRX $0.71
  • WFCF $9.26
  • 52 Week High
  • IFRX $2.82
  • WFCF $13.78
  • Technical
  • Relative Strength Index (RSI)
  • IFRX 55.06
  • WFCF 58.62
  • Support Level
  • IFRX $1.29
  • WFCF $13.00
  • Resistance Level
  • IFRX $1.44
  • WFCF $13.57
  • Average True Range (ATR)
  • IFRX 0.14
  • WFCF 0.24
  • MACD
  • IFRX -0.00
  • WFCF -0.07
  • Stochastic Oscillator
  • IFRX 48.84
  • WFCF 32.08

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

Share on Social Networks: